Sean Grant, CHIEF FINANCIAL OFFICER at Vera Therapeutics, Inc. (VERA), sold 232,831 shares at $40.06 ($9.2M) on 2024-04-03, disclosed to the SEC on 2024-04-05.
Open-market sale of $9.2M VERA by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.13 | 11,648 | $444K | 4.8% |
| 2 | $38.13 | 11,648 | $444K | 4.8% |
| 3 | $38.20 | 78 | $3K | 0.0% |
| 4 | $38.22 | 672 | $26K | 0.3% |
| 5 | $38.22 | 3,112 | $119K | 1.3% |
| 6 | $38.22 | 387 |
| $15K |
| 0.2% |
| 7 | $38.22 | 3,112 | $119K | 1.3% |
| 8 | $38.23 | 201 | $8K | 0.1% |
| 9 | $38.65 | 10,988 | $425K | 4.6% |
| 10 | $38.65 | 10,988 | $425K | 4.6% |
| 11 | $39.19 | 2,944 | $115K | 1.3% |
| 12 | $39.19 | 366 | $14K | 0.2% |
| 13 | $39.19 | 639 | $25K | 0.3% |
| 14 | $39.19 | 2,944 | $115K | 1.3% |
| 15 | $39.20 | 203 | $8K | 0.1% |
| 16 | $39.22 | 80 | $3K | 0.0% |
| 17 | $39.25 | 7,361 | $289K | 3.1% |
| 18 | $39.25 | 7,361 | $289K | 3.1% |
| 19 | $40.05 | 69,831 | $2.8M | 30.3% |
| 20 | $40.05 | 453 | $18K | 0.2% |
| 21 | $40.05 | 69,831 | $2.8M | 30.3% |
| 22 | $40.06 | 1,505 | $60K | 0.7% |
| 23 | $40.06 | 867 | $35K | 0.4% |
| 24 | $40.06 | 177 | $7K | 0.1% |
| 25 | $40.06 | 1,505 | $60K | 0.7% |
| 26 | $40.06 | 6,965 | $279K | 3.0% |
| 27 | $40.06 | 6,965 | $279K | 3.0% |
| Total | $39.59 avg | 232,831 | $9.2M | 100% |
| Filing → |
| VERA | BUY | 2023-02-17 | $100K | — | Filing → |
| VERA | BUY | 2023-02-08 | $100K | — | Filing → |
| VERA | BUY | 2022-06-16 | $68K | — | Filing → |